As of September 30, 2024, Ping An Biomedical Co., Ltd. has 20.50M shares outstanding.
| Shares Outstanding | 20.50M |
As of September 30, 2024, Ping An Biomedical Co., Ltd. maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.84 |
| Quick Ratio | 0.64 |
| Debt / Equity | -150.41 |
As of the close on November 16, 2026, Ping An Biomedical Co., Ltd.'s stock has declined approximately 93.98% over the past 52 weeks. The 50-day moving average sits at 4.42, while the 200-day moving average is 5.78.
| 52-Week Price Change | -93.98% |
| 50-Day Moving Average | 4.42 |
| 200-Day Moving Average | 5.78 |
As of September 30, 2024, Ping An Biomedical Co., Ltd. holds 18,657.71 in cash and equivalents against 1.54M in total debt, resulting in a net debt position of 1.41M. Total book value stands at -1.02M, with working capital of -1.46M providing operational flexibility.
| Cash & Cash Equivalents | 18,657.71 |
| Total Debt | 1.54M |
| Net Debt | 1.41M |
| Equity (Book Value) | -1.02M |
| Book Value Per Share | -0.05 |
| Working Capital | -1.46M |
Ping An Biomedical Co., Ltd.'s most recent stock split took place on October 23, 2026 with a 40:1 split ratio.
| Last Split Date | 10/23/2026 |
| Split Ratio | 40:1 |
Already premium?